![Dana Hilt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dana Hilt
Chief Tech/Sci/R&D Officer at
ACTINOGEN MEDICAL LIMITED
Net worth: 974 000 $ as of 2026-09-29
Profile
Dr. Dana C.
Hilt, MD, is a Chief Medical Officer at Actinogen Medical Ltd. Dr. Hilt was previously employed as a Chief Medical Officer by Frequency Therapeutics, Inc., a Chief Medical Officer by Lysosomal Therapeutics, Inc., a Chief Medical Officer by Critical Therapeutics, Inc., a Chief Medical Officer & SVP-Drug Development by FORUM Pharmaceuticals, Inc., a Director-Clinical Neurosciences by Amgen, Inc., a Chief Medical Officer by Ascend Pharmaceuticals, Inc., a Chief Medical Officer & SVP-Clinical Research by ASCEND Therapeutics US LLC, a Chief Medical Officer by Brenig Therapeutics, Inc., and a Vice President-Clinical Research by Guilford Pharmaceuticals, Inc. He received his undergraduate degree from the University of Maine and a doctorate degree from Tufts University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-08-07 | 25,000,000 ( 0.65% ) | 974 000 $ | 2026-09-29 |
Dana Hilt active positions
| Companies | Position | Start |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Chief Tech/Sci/R&D Officer | 2023-01-31 |
Former positions of Dana Hilt
| Companies | Position | End |
|---|---|---|
Brenig Therapeutics, Inc.
 Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Chief Tech/Sci/R&D Officer | 2025-06-09 |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Chief Tech/Sci/R&D Officer | 2019-07-31 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Chief Tech/Sci/R&D Officer | 2007-09-24 |
ASCEND Therapeutics US LLC
 ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Chief Tech/Sci/R&D Officer | - |
| KORRO BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Education of Dana Hilt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
 Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ascend Pharmaceuticals, Inc. | |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
- Stock Market
- Insiders
- Dana Hilt
